Skip to content
Use caution Drug recall · FDA · Published June 27, 2016

Sun Pharma Recalls Carvedilol Tablets Due to Impurity Issues

Sun Pharmaceutical recalls specific lots of Carvedilol Tablets USP, 3.125 mg due to failed impurity specifications. Check your bottle NDC and lot number.

🇺🇸 FDA recall #D-1504-2016DrugSun Pharmaceutical ›
Take action

Contact the company

Recalling firmSun Pharmaceutical Industries, Inc.270 Prospect Plains Rd · Cranbury, NJ 08512-3605
✎ GovInfoNow plain-language explainer

What happened, in plain English

Sun Pharmaceutical Industries, Inc. is recalling Carvedilol Tablets USP, 3.125 mg because they failed impurity and degradation specifications. The affected products are distributed in 100-count, 500-count, and 1000-count bottles. Consumers should check their medication against the specific lot numbers listed in the recall notice. Read more at govinfonow.com/recall/42570-sun-pharma-recalls-carvedilol-tablets-due-to-impurity-issues.

Source Summary by GovInfoNow · govinfonow.com/recall/42570-sun-pharma-recalls-carvedilol-tablets-due-to-impurity-issues · Updated October 9, 2026 · FDA enforcement record: FDA #D-1504-2016

Cite this page

“Sun Pharma Recalls Carvedilol Tablets Due to Impurity Issues.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42570-sun-pharma-recalls-carvedilol-tablets-due-to-impurity-issues. Based on FDA recall #D-1504-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1504-2016%22&limit=1).

Why it’s dangerous

The tablets failed impurity and degradation specifications, which means the chemical composition of the drug may not meet safety or quality standards. While the record does not specify exact health consequences, taking medication with failed specifications can result in receiving less or more than the intended dose, potentially affecting treatment efficacy or safety.

Who’s affected

Patients currently taking Carvedilol Tablets USP, 3.125 mg from Sun Pharmaceutical Industries, Inc. are affected. Individuals who purchased these specific bottles nationwide between the manufacturing date and the recall date may have the impacted product.

How to tell if you have this one

Look for Carvedilol Tablets USP, 3.125 mg distributed by Sun Pharmaceutical Industries, Inc. Check the bottle for NDC codes 57664-242-88 (100-count), 57664-242-13 (500-count), or 57664-242-18 (1000-count). Verify the lot numbers are AVF0246/A, AVF0247/B, AVF0246/B, or AVF0246/C.

  • Brand
    Sun Pharmaceutical
  • Category
    Drug
FDA recall event · 4 products

All 4 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class III
  • Status
    Terminated
  • Distribution
    Nationwide
Recall numberProduct, codes & lotsQuantity
D-1504-2016Carvediol Tablets , USP, 3.125 mg, 100-count bottle (NDC 57664-242-88). 500-count bottle (NDC 57664-242-13), 1000-count bottle (NDC 57664-242-18), Rx Only Manufactured by: ALKALOIDA Chemical Company Zrt 440 Tisavasvari Kabay Janos u. 29 Hungary, Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512; Lot #: AVF0246/A, AVF0247/B, AVF0246/B, AVF0246/C; Exp. 02/174,656 HDPE bottles
D-1505-2016Carvediol Tablets, USP, 6.25 mg, 100-count bottle (NDC 57664-244-18), 500-count bottle (NDC 57664-244-13), 1000-count bottle (NDC 57664-244-18), Rx Only, Manufactured by: ALKALOIDA Chemical Company Zrt 440 Tisavasvari Kabay Janos u. 29 Hungary, Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512; Lot #: AVF0254/C, AVF0254/B, AVF0254/C; Exp. 02/172,952 HDPE bottles
D-1506-2016Carvediol Tablets, USP, 12.5 mg, 500-count bottle (NDC 57664-245-13), 1000-count bottle (NDC 57664-245-18), Rx Only Manufactured by: ALKALOIDA Chemical Company Zrt 440 Tisavasvari Kabay Janos u. 29 Hungary, Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512; Lot #: AVF0256/A , AVF0256/B, AVF0256/C; Exp. 02/17612 HDPE bottles
D-1507-2016Carvediol Tablets, USP, 25 mg, 100-count bottle (NDC 57664-247-88), 500-count bottle (NDC 57664-247-13), 1000-count bottle (NDC 57664-247-18), Rx Only Manufactured by: ALKALOIDA Chemical Company Zrt 440 Tisavasvari Kabay Janos u. 29 Hungary, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512; Lot # AVF0258/A, AVF0258/B, AVF0258/C, AVF0259/A, AVF0259/C; Exp. 02/173,889 HDPE bottles
Based on the official FDA remedy

What to do — step by step

  1. Check Your Medication

    Compare your Carvedilol Tablets USP bottle against the NDC codes and lot numbers listed in the recall to see if it is affected.

  2. Contact Your Pharmacist

    Speak with your pharmacist or healthcare provider immediately to discuss how to handle the recalled medication and obtain a replacement if necessary.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 21 months after the firm started it.

1. Firm started the recall: Jun 27, 201612. FDA classified it Class III: Sep 16, 201623. Published in FDA’s Enforcement Report: Sep 28, 201634. FDA terminated the recall: Mar 26, 2018420162018
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Sun Pharmaceutical recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1504-2016 (June 27, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1504-2016 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA